BeStock  
Stocks › Biotechnology › SRRK

Scholar Rock SRRK

US equityMarket cap rank #1884Biotechnology
$48.13 −$2.24 (-4.45%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $48.13 0.00%
Open$49.63
Prev close$50.37
Day range$47.94 – $52.17
Volume2.08M
Market cap$5.87B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership120.2%+1.77 pts vs. prior quarter
Institutions holding388+14 vs. prior quarter
Insider trades (recent)24 buys / 26 sellsNet selling
Short interest19.28% of floatDays to cover 13.6 · as of 30 Oct 2026
Short-sale volume share23.5%5-day average of daily volume

Short-sale volume as % of daily volume

13%26%39%52%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$15.50M (9 inflow days, 11 outflow days).

Net flow by order size, last 20 sessions

+$14.1MSuper+$1.4MBig+$329.1KMid−$3.3MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 41.8% of shares outstanding.

Largest holders

  • FMR14.92%
  • BlackRock7.85%
  • Artal Group S.A.7.68%
  • Samsara BioCapital LLC5.82%
  • T. Rowe Price Group, Inc.5.57%
  • Wellington Management Group5.51%
  • Orbis Investment Management Limited4.86%
  • Vanguard Capital Management, LLC3.95%

By investor type

  • Mutual Fund82.63%
  • VC/PE Fund16.41%
  • Hedge Fund12.45%
  • Public Company3.76%
  • Sovereign Wealth Fund2.27%
  • Private Company1.07%
  • Individual/Insider1.00%
  • Government Pension Fund0.74%

Reported short interest has risen from 14.96% to 19.28% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +1,955,530 2.4%
GW&K Investment Management, LLC Mutual Fund 2026/Q3 +362,884 0.3%
UBS Asset Management Mutual Fund 2026/Q3 +261,932 0.7%
Fiera Capital Corporation Mutual Fund 2026/Q3 +248,615 0.2%
Morgan Stanley Public Company 2026/Q3 +215,497 1.4%
FMR Mutual Fund 2026/Q3 +212,086 14.9%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +338,984 0.4%
MFS Investment Management Mutual Fund 2026/Q3 +2,607,348 2.1%
BlackRock Mutual Fund 2026/Q3 +2,024,791 7.8%
Orbis Investment Management Limited Mutual Fund 2026/Q3 +1,753,550 4.9%
Morgan Stanley Public Company 2026/Q3 +1,311,058 1.2%
Adage Capital Management, L.P. Hedge Fund 2026/Q3 +1,031,402 1.4%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +1,017,568 4.5%
Putnam LLC Mutual Fund 2026/Q3 +845,240 0.7%
FMR Mutual Fund 2026/Q3 +752,087 14.8%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
25 Oct 2026 Samsara BioCapital LLC Open Market Acquisition +289,470 $41.82 7,103,537
23 Sep 2026 Robert Woods Chief Operating Officer Other Disposition -48,034 – 48,034
20 Sep 2026 David Hallal Chairperson & CEO Other Disposition -36,652 – 403,530
30 Jun 2026 Michael Gilman Independent Director & Member of Scientific Advisory Board Automatic Disposition -2,544 $54.81 52,672
30 Jun 2026 Jeffrey Flier Independent Director & Member of Scientific Advisory Board Automatic Disposition -3,053 $54.88 21,017
30 Jun 2026 Kristina Burow Independent Director Automatic Disposition -3,053 $54.28 107,818
30 Jun 2026 Joshua Reed Independent Director Automatic Disposition -3,053 $54.28 12,679
30 Jun 2026 Katie Peng Independent Director Automatic Disposition -5,446 $54.96 21,500
3 Jun 2026 Michael Gilman Independent Director & Member of Scientific Advisory Board Other Acquisition +6,839 – 6,839
3 Jun 2026 Michael Gilman Independent Director & Member of Scientific Advisory Board Other Derivative Acquisition +4,310 $45.33 4,310
3 Jun 2026 Srinivas Akkaraju Independent Director Other Acquisition +6,839 – 6,839
3 Jun 2026 Srinivas Akkaraju Independent Director Other Derivative Acquisition +4,310 $45.33 4,310
3 Jun 2026 Jeffrey Flier Independent Director & Member of Scientific Advisory Board Other Acquisition +6,839 – 6,839
3 Jun 2026 Jeffrey Flier Independent Director & Member of Scientific Advisory Board Other Derivative Acquisition +4,310 $45.33 4,310
3 Jun 2026 Kristina Burow Independent Director Other Acquisition +6,839 – 6,839
3 Jun 2026 Kristina Burow Independent Director Other Derivative Acquisition +4,310 $45.33 4,310
3 Jun 2026 Richard Brudnick Independent Director Other Acquisition +6,839 – 6,839
3 Jun 2026 Richard Brudnick Independent Director Other Derivative Acquisition +4,310 $45.33 4,310
3 Jun 2026 Joshua Reed Independent Director Other Acquisition +6,839 – 6,839
3 Jun 2026 Joshua Reed Independent Director Other Derivative Acquisition +4,310 $45.33 4,310

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 23,477,706 19.3% 13.6
15 Oct 2026 22,175,999 18.2% 12.7
30 Sep 2026 22,722,119 18.7% 9.3
15 Sep 2026 19,407,706 15.9% 10.8
31 Aug 2026 18,008,058 14.8% 15.4
14 Aug 2026 18,218,515 15.0% 19.8

Discussion

No comments yet — be the first to weigh in on SRRK.

Sign in to join the discussion.

Scroll to Top